| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661c68977a99ccd5a68ea29d1b870a1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e96a7912a4e01334aca3ffd3babe863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d42072aec4e66dfbc70d30132ab1ca90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b7f64f380c538d4b6aa024f05455da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 |
| filingDate |
2015-12-14^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6185536351d96012a5b27ef1e8432dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7bd1adc8358214513ce784a2349fb59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9384e992e8d37ace2a8474dda5032829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ea6c0e08814baf951802d3753c9b59e |
| publicationDate |
2016-06-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016100154-A1 |
| titleOfInvention |
Pyrrolidine orexin receptor antagonists |
| abstract |
The present invention is directed to pyrrolidine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10150751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10214535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10227336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10435398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020203609-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020017569-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10011595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000499-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10017504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9994570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10308645-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10155750-B2 |
| priorityDate |
2014-12-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |